| Financial Year |
March 31 2023 |
| Monetary Funds |
716,613,610.34 |
| Held-for-trading Financial Assets |
20,000,000.00 |
| Notes Receivable |
136,659,099.21 |
| Accounts Receivable |
283,481,537.86 |
| Advances to Suppliers |
4,520,826.19 |
| Other Receivables |
6,619,607.02 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
215,876,775.43 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
31,806,090.06 |
| Total Current Assets |
1,429,047,701.05 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
247,965,029.75 |
| Investment Properties |
-- |
| Fixed Assetes |
2,093,167,542.84 |
| Under-construction Projects |
26,199,343.27 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
108,428,458.03 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
12,509,275.50 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
2,490,452,193.67 |
| Total Assets |
3,919,499,894.72 |
| Short-Term Loans |
581,979,726.47 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
217,038,255.34 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,314,747.06 |
| Taxes Payable |
19,666,378.10 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
44,122,762.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
74,585,452.05 |
| Other Current Liabilities |
2,297,337.36 |
| Sub-Total of Current Liabilities |
980,144,845.09 |
| Long-term Loans |
300,341,458.32 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
1,492,888.82 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
404,787,723.62 |
| Total Liabilities |
1,384,932,568.71 |
| Paid-In Capital(Or Share Stock) |
400,100,000.00 |
| Capital Surplus |
715,966,696.48 |
| Surplus Reserve |
129,363,010.03 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
832,149,228.64 |
| Minority Stockholder's Interest |
456,988,390.86 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,077,578,935.15 |
| Owner's Equity（Stockholder's Equity） |
2,534,567,326.01 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,919,499,894.72 |
